Quantcast

The BioFlorida Board of Directors announced Nancy Bryan as the new president & CEO of Florida’s life sciences industry association. Bryan will lead and direct BioFlorida’s programs and advocacy initiatives during a time of impressive growth within the industry. According to BioFlorida’s most recent edition of Florida’s BioPulse, Florida’s biotechnology sector grew by 60 percent over the past five years compared to a nationwide increase of less than five percent over the same period. Furthermore, the number of biotechnology companies in Florida has increased by 13.5 percent since the first quarter of 2012.

“Life science businesses are growing in Florida and the industry is seeing the number of biotechnology start-ups increase every quarter,” said Stephanie Warrington, chair of the BioFlorida Board of Directors and president of TrueMotion Spine Inc. “Nancy’s extensive industry background will be invaluable as BioFlorida continues to advance the business of life sciences in Florida.”

Bryan brings a breadth of experience to BioFlorida, having held management positions in top-tier and specialty biotech and pharmaceutical companies, where she played a key role in establishing and leading commercial organizations. Bryan has successfully developed, launched and commercialized blockbusters (Zantac), primary care drugs (Levitra), major biologics (Tysabri) and orphan drugs for rare diseases (Supprelin LA for precious puberty), and has created franchises in a variety of therapeutic areas including oncology, anti-infectives, gastrointestinal, urology and autoimmune.

She has more than 25 years of global commercial experience—serving as senior vice president of commercial operations at NPS Pharmaceuticals, senior vice president of marketing and sales for Indevus Pharmaceuticals and head of commercial operations at Elan Pharmaceuticals for the global autoimmune franchise. Earlier in her career, Bryan held positions of increasing scope and responsibility at leading pharmaceutical companies including GlaxoSmithKline and Bayer Healthcare. Bryan graduated with honors from Columbia University, receiving an MBA in marketing and business economics and obtained her Bachelor of Arts in economics with honors from the University of Virginia.

“The Search Committee had the difficult task of choosing one person to lead our organization from the very large pool of extremely qualified candidates for the position,” said Leslie Croland, a partner with Duane Morris and chair of BioFlorida’s Search Committee. “After carefully considering all of the applicants, we are confident that Nancy will apply her outstanding business experience and leadership skills to help us build on the current momentum of Florida’s growing life sciences community.”

Bryan will be welcomed at the 10th Annual Celebration of Biotechnology on May 9, at the RTI Biologics Campus. The Celebration is one of BioFlorida’s largest events, second to the annual conference. The Alachua event is expected to draw hundreds of biotechnology professionals, investors, scientists and decision makers from the local area and across the state. The event is free to the public. To learn more, click here, or visit bioflorida.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*